Nexus Pharma products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Karachi · Pakistan
Karachi pharmaceutical manufacturer and marketer of branded generics across primary-care and specialist therapeutic segments.
Nexus Pharma products in Pakistan
Nexus Pharma (Pvt) Ltd has 52 medicine presentations registered in Pakistan under 28 brands, covering 24 generic medicines. Most of its products are in Anti-infectives, Pain & musculoskeletal and CNS & mental health. Its brands with the most registered strengths and packs are Budex (Ibuprofen), Rithinex (Clarithromycin), Eftax (Ceftazidime) and Linez (Linezolid). 52 products have an official DRAP price on MedInfoBase. See all 28 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Nexus Pharma (Pvt.) Ltd.
- Company type
- Private pharmaceutical manufacturer
- Address
- Plot No. 4/19-4/36, Sector 21, Industrial Area, Karachi 74900, Pakistan · 74900
- Website
- nexuspharma.com.pk ↗
- Phone
- +92 21 35002381-84
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 88%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Nexus Pharma (Pvt) Ltd is priced against the market
49 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Arti | Artemether | 20 mg | Tablet | 2 x 8's | 055033 | PKR 620.91 | PKR 38.81/tablet | 🔒 Pharma Pro |
| Artinex | Artemether | 80 mg/mL | Injection | 1 ml x 6's amp | 055032 | PKR 1,164.20 | — | No comparator |
| Budex | Ibuprofen | 100 mg/5 mL | Suspension | 90ml | 039537 | PKR 59.56 | PKR 0.66/mL | 🔒 Pharma Pro |
| Budex | Ibuprofen | 100 mg/5 mL | Suspension | 120ml | 039537 | PKR 129.12 | PKR 1.08/mL | 🔒 Pharma Pro |
| Budex | Ibuprofen | 100 mg/5 mL | Suspension | 60ml | 039537 | PKR 40.41 | PKR 0.67/mL | 🔒 Pharma Pro |
| Budex | Ibuprofen | 200 mg/5 mL | Suspension | 90ml | 075832 | PKR 116.42 | PKR 1.29/mL | 🔒 Pharma Pro |
| Budex | Ibuprofen | 200 mg/5 mL | Suspension | 60ml | 075832 | PKR 77.62 | PKR 1.29/mL | 🔒 Pharma Pro |
| Cinmox | Moxifloxacin | 400 mg | Tablet | 5's | 055056 | PKR 929.15 | PKR 185.83/tablet | 🔒 Pharma Pro |
| Coozip | Omeprazole | 20 mg | Capsule | 1x14's | 039633 | PKR 279.41 | PKR 19.96/capsule | 🔒 Pharma Pro |
| Dimisinex | Dihydroartemisinin + Piperaquine | 320 mg + 320 mg | Tablet | 8's | 075835 | PKR 743.32 | PKR 92.92/tablet | No comparator |
| Dogrinex | Clopidogrel | 75 mg | Tablet | 10's | 061592 | PKR 273.86 | PKR 27.39/tablet | 🔒 Pharma Pro |
| Eftax | Ceftazidime | 1 g | Injection | 1Vial | 031945 | PKR 436.57 | PKR 436.57/vial/unit | 🔒 Pharma Pro |
| Eftax | Ceftazidime | 250 mg | Injection | 1Vial | 031946 | PKR 159.94 | PKR 159.94/vial/unit | 🔒 Pharma Pro |
| Eftax | Ceftazidime | 500 mg | Injection | 1Vial | 031947 | PKR 243.30 | PKR 243.30/vial/unit | 🔒 Pharma Pro |
| Eycip | Ciprofloxacin | 3 mg/5 mL | Ophthalmic drops | 5ml | 039567 | PKR 184.33 | PKR 36.87/mL | No comparator |
| Eyfo | Ofloxacin | 3 mg/mL | Ophthalmic drops | 5ml | 042183 | PKR 155.23 | PKR 31.05/mL | 🔒 Pharma Pro |
| Gyala | Cefixime | 100 mg/5 mL | Suspension | 30 ml | 039635 | PKR 314.83 | PKR 10.49/mL | 🔒 Pharma Pro |
| Gyala | Cefixime | 400 mg | Capsule | 5's | 039636 | PKR 564.17 | PKR 112.83/capsule | 🔒 Pharma Pro |
| Lekra | Levetiracetam | 750 mg | Tablet | 10's | 061308 | PKR 1,336.14 | PKR 133.61/tablet | 🔒 Pharma Pro |
| Levilox | Levofloxacin | 250 mg | Tablet | 10's | 055059 | PKR 257.40 | PKR 25.74/tablet | 🔒 Pharma Pro |
| Levilox | Levofloxacin | 500 mg | Tablet | 10's | 055060 | PKR 426.33 | PKR 42.63/tablet | 🔒 Pharma Pro |
| Linez | Linezolid | 600 mg | Tablet | 12's | 061309 | PKR 4,178.26 | PKR 348.19/tablet | 🔒 Pharma Pro |
| Linez | Linezolid | 100 mg/5 mL | Dry suspension | 60 ml | 081594 | PKR 684.64 | PKR 11.41/mL | 🔒 Pharma Pro |
| Linez | Linezolid | 100 mg/5 mL | Dry suspension | 120 ml | 081594 | PKR 1,300.81 | PKR 10.84/mL | 🔒 Pharma Pro |
| Micnex | Miconazole | 20 mg | Gel | 20gm | 039553 | PKR 170.19 | PKR 8.51/g | 🔒 Pharma Pro |
| Migrinex | Sumatriptan | 50 mg | Tablet | 6's | 088313 | PKR 682.83 | PKR 113.81/tablet | 🔒 Pharma Pro |
| Migrinex | Sumatriptan | 50 mg | Tablet | 12's | 088313 | PKR 1,365.66 | PKR 113.81/tablet | 🔒 Pharma Pro |
| Nepamen Eye Drops 0.1%Registry verified | NEPAFENAC | — | — | — | 137332Official source ↗ | No indexed price | — | — |
| New-Fort | Cefotaxime | 1 g | IV injection | 1's | 083171 | PKR 246.89 | PKR 246.89/vial/unit | 🔒 Pharma Pro |
| Nexcip | Ciprofloxacin | 250 mg | Tablet | 10's | 055057 | PKR 252.24 | PKR 25.22/tablet | 🔒 Pharma Pro |
| Nexcip | Ciprofloxacin | 500 mg | Tablet | 10's | 055058 | PKR 417.17 | PKR 41.72/tablet | 🔒 Pharma Pro |
| Nexcip | Ciprofloxacin | 2 mg/mL | IV infusion | 50ml | 067416 | PKR 116.42 | PKR 2.33/mL | 🔒 Pharma Pro |
| Nexmet | Metronidazole | 200 mg/5 mL | Suspension | 60ml | 039542 | PKR 62.09 | PKR 1.03/mL | 🔒 Pharma Pro |
| Nitaxim | Cefotaxime | 250 mg | Injection | 1Vial | 039561 | PKR 105.67 | PKR 105.67/vial/unit | 🔒 Pharma Pro |
| Nitaxim | Cefotaxime | 500 mg | Injection | 1Vial | 039562 | PKR 159.25 | PKR 159.25/vial/unit | 🔒 Pharma Pro |
| Nitaxim | Cefotaxime | 1 g | Injection | 1Vial | 039563 | PKR 286.43 | PKR 286.43/vial/unit | 🔒 Pharma Pro |
| Onznex | Azithromycin | 200 mg/5 mL | Dry suspension | 15ml | 055068 | PKR 322.76 | PKR 21.52/mL | 🔒 Pharma Pro |
| Onznex | Azithromycin | 250 mg | Tablet | 6's | 055069 | PKR 293.41 | PKR 48.90/tablet | 🔒 Pharma Pro |
| Onznex | Azithromycin | 500 mg | Tablet | 6's | 055070 | PKR 537.93 | PKR 89.66/tablet | 🔒 Pharma Pro |
| Pedixime | Cefuroxime | 250 mg | Injection | 5 Vial | 039559 | PKR 273.86 | PKR 54.77/vial/unit | 🔒 Pharma Pro |
| Pedixime | Cefuroxime | 750 mg | Injection | 1Vial | 039560 | PKR 195.61 | PKR 195.61/vial/unit | 🔒 Pharma Pro |
| Potrinex | Calcipotriol | 0.005% | Ointment | 30gm | 098653 | PKR 610.76 | PKR 20.36/g | 🔒 Pharma Pro |
| Rithinex | Clarithromycin | 125 mg/5 mL | Suspension | 90ml | 055064 | PKR 650.01 | PKR 7.22/mL | 🔒 Pharma Pro |
| Rithinex | Clarithromycin | 125 mg/5 mL | Suspension | 120ml | 055064 | PKR 822.70 | PKR 6.86/mL | 🔒 Pharma Pro |
| Rithinex | Clarithromycin | 125 mg/5 mL | Suspension | 60ml | 055064 | PKR 432.70 | PKR 7.21/mL | 🔒 Pharma Pro |
| Rithinex | Clarithromycin | 250 mg | Tablet | 10's | 055065 | PKR 465.69 | PKR 46.57/tablet | 🔒 Pharma Pro |
| Rithinex | Clarithromycin | 500 mg | Tablet | 10's | 055066 | PKR 863.44 | PKR 86.34/tablet | 🔒 Pharma Pro |
| Thioprim | Azathioprine | 50 mg | Tablet | 10's | 088173 | PKR 197.69 | PKR 19.77/tablet | 🔒 Pharma Pro |
| Zefung | Fluconazole | 50 mg | Capsule | 7's | 039545 | PKR 873.16 | PKR 124.74/capsule | 🔒 Pharma Pro |
| Zefung Dry | Fluconazole | 50 mg/5 mL | Dry suspension | 35 ml | 081593 | PKR 407.47 | PKR 11.64/mL | 🔒 Pharma Pro |
All 28 Nexus Pharma brands in Pakistan
- Arti Artemether · 20 mg tablet
- Artinex Artemether · 80 mg/mL injection
- Budex Ibuprofen · 100 mg/5 mL suspension, 200 mg/5 mL suspension
- Cinmox Moxifloxacin · 400 mg tablet
- Coozip Omeprazole · 20 mg capsule
- Dimisinex Dihydroartemisinin + Piperaquine · 320 mg + 320 mg tablet
- Dogrinex Clopidogrel · 75 mg tablet
- Eftax Ceftazidime · 1 g injection, 250 mg injection, 500 mg injection
- Eycip Ciprofloxacin · 3 mg/5 mL drops
- Eyfo Ofloxacin · 3 mg/mL drops
- Gyala Cefixime · 100 mg/5 mL suspension, 400 mg capsule
- Lekra Levetiracetam · 750 mg tablet
- Levilox Levofloxacin · 250 mg tablet, 500 mg tablet
- Linez Linezolid · 100 mg/5 mL suspension, 600 mg tablet
- Micnex Miconazole · 20 mg gel
- Migrinex Sumatriptan · 50 mg tablet
- New-Fort Cefotaxime · 1 g injection
- Nexcip Ciprofloxacin · 2 mg/mL infusion, 250 mg tablet, 500 mg tablet
- Nexmet Metronidazole · 200 mg/5 mL suspension
- Nitaxim Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
- Onznex Azithromycin · 200 mg/5 mL suspension, 250 mg tablet, 500 mg tablet
- Pedixime Cefuroxime · 250 mg injection, 750 mg injection
- Potrinex Calcipotriol · 0.005% ointment
- Rithinex Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 500 mg tablet
- Thioprim Azathioprine · 50 mg tablet
- Zefung Fluconazole · 50 mg capsule
- Zefung Dry Fluconazole · 50 mg/5 mL suspension
- Zocef Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
Nexus Pharma: common questions
How many products does Nexus Pharma have in Pakistan?
Nexus Pharma (Pvt) Ltd has 52 registered medicine presentations in Pakistan, sold under 28 brands and covering 24 generic medicines.
What are the main brands of Nexus Pharma?
By number of registered strengths and packs, its largest brands are Budex (Ibuprofen), Rithinex (Clarithromycin), Eftax (Ceftazidime), Linez (Linezolid) and Nexcip (Ciprofloxacin). This is not a sales ranking.
Which therapy areas does Nexus Pharma cover?
The most products are in Anti-infectives (40), Pain & musculoskeletal (5), CNS & mental health (3), Gastrointestinal & hepatology (1) and Hematology & thrombosis (1).
Where can I see Nexus Pharma medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.